Lucid Diagnostics Inc. (LUCD) NASDAQ
1.05
+0.02(+1.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.05
+0.02(+1.94%)
Currency In USD
| Market Cap | 111.12M |
| Enterprise Value | 102.24M |
| P/E Ratio | -2.38 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 20.92 |
| Price/Book Ratio | 26.76 |
| Enterprise/Revenue | 20.71 |
| Enterprise/EBITDA | -2.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -8.77 |
| Operating Margin | -9.6 |
| Return On Assets | -1.32 |
| Return On Equity | -3.7 |
| Revenue | 4.71M |
| Revenue/Share | 0.05 |
| Gross Profit | -2.84M |
| EBITDA | -48.77M |
| Net Income | -58.01M |
| Diluted EPS | -0.69 |
| Total Cash | 27.88M |
| Total Cash/Share | 0.27 |
| Total Debt | 26.8M |
| Total Debt/Equity | 6.7 |
| Current Ratio | 1.07 |
| Book Value Per Share | 0.04 |
| 52-Week Change | -16 |
| 52-Week High | 1.63 |
| 52-Week Low | 0.9 |
| Moving Average 50 Days | 1.12 |
| Moving Average 200 Days | 1.16 |
| Average Volume | 810,374 |
| Shares Outstanding | 102.3M |
| % Held by Institutions | 34.9 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |